Sherry Aulin, Chief Financial Officer at Xenon Pharmaceuticals Inc. (XENE), sold 34,003 shares at $39.57 ($1.3M) on 2022-09-02, disclosed to the SEC on 2022-09-07.
Open-market sale of $1.3M XENE by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.53 | 3,293 | $130K | 9.7% |
| 2 | $39.57 | 15,355 | $608K | 45.2% |
| 3 | $39.57 | 15,355 | $608K | 45.2% |
| Total | $39.57 avg | 34,003 | $1.3M | 100% |